In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...